BlackRock Health Sciences Term Trust Declares Monthly Dividend of $0.11 (NYSE:BMEZ)

Posted by Brian Himes on May 13th, 2026

BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) declared a monthly dividend on Friday, February 27th. Shareholders of record on Friday, May 15th will be given a dividend of 0.11 per share on Friday, May 29th. This represents a c) dividend on an annualized basis and a dividend yield of 9.3%. The ex-dividend date of this dividend is Friday, May 15th.

BlackRock Health Sciences Term Trust Price Performance

Shares of NYSE BMEZ opened at $14.17 on Wednesday. BlackRock Health Sciences Term Trust has a 1 year low of $13.67 and a 1 year high of $15.80. The firm has a fifty day moving average price of $14.28 and a 200-day moving average price of $14.84.

Institutional Investors Weigh In On BlackRock Health Sciences Term Trust

Institutional investors and hedge funds have recently bought and sold shares of the business. Baird Financial Group Inc. purchased a new stake in shares of BlackRock Health Sciences Term Trust during the first quarter worth about $189,000. Geneos Wealth Management Inc. bought a new stake in BlackRock Health Sciences Term Trust during the 1st quarter valued at approximately $40,000. NewEdge Advisors LLC lifted its holdings in BlackRock Health Sciences Term Trust by 134.3% in the 2nd quarter. NewEdge Advisors LLC now owns 48,300 shares of the company’s stock worth $689,000 after purchasing an additional 27,686 shares in the last quarter. Jane Street Group LLC boosted its stake in BlackRock Health Sciences Term Trust by 157.1% in the 2nd quarter. Jane Street Group LLC now owns 97,472 shares of the company’s stock worth $1,390,000 after purchasing an additional 59,559 shares during the period. Finally, Ameriprise Financial Inc. boosted its stake in BlackRock Health Sciences Term Trust by 14.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 14,521 shares of the company’s stock worth $212,000 after purchasing an additional 1,787 shares during the period.

About BlackRock Health Sciences Term Trust

(Get Free Report)

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.